Ipamorelin is a pentapeptide and a selective ghrelin receptor agonist known as a Growth Hormone Secretagogue (GHS). In laboratory research, it is utilized to study the pulsatile release of endogenous growth hormone (GH) by stimulating the pituitary gland without significantly impacting prolactin, cortisol, or ACTH levels. For research use only.
Ipamorelin is a specialized research reagent classified as a Growth Hormone Releasing Peptide (GHRP). It is engineered for the study of growth hormone kinetics and pituitary function. In research settings, it is valued for its precision; it provides highly selective GH release, which allows scientists to evaluate metabolic shifts, tissue architectural restoration, and lipid oxidation in a controlled environment. This reagent is specifically valued for its selectivity, ensuring that the stimulation of the GH axis does not cross-react with other hormonal pathways. This allows for the study of nitrogen retention and protein synthesis without broad-spectrum hormonal activation. Supplied as a purified powder, it is intended strictly for laboratory research and is not for human or veterinary administration.
